Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-07-18FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
The FDA approved Sandoz's supplemental application for the adalimumab biosimilar ADALIMUMAB-ADAZ. The approval covers multiple inflammatory …
-
FDA approval · 2022-07-18FDA Approved: FENOPRON TM — Original Application (Galt Pharmaceuticals, LLC)
FDA approved Fenoprofen calcium as a generic tablet under an original ANDA submitted by Galt Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Phase 2]
Phase 2 trial evaluating GLPG3970 as an oral treatment for 6 weeks in adults with moderately to severely active rheumatoid arthritis who had…
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Randomized Controlled RSA Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty. [NA]
Completed randomized controlled trial comparing Taperloc Complete vs Taperloc Complete Microplasty in hip arthroplasty; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis [Phase 2]
Open-label extension study assessing safety and efficacy of upadacitinib (ABT-494) in adults with rheumatoid arthritis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-07-11FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction [Phase 4]
Phase 4 trial comparing active conventional therapy to three biologic treatments in early rheumatoid arthritis with subsequent dose reductio…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of Colquhounia Root Tablet in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity [Phase 4]
Phase 4 trial update examining dose reduction for early rheumatoid arthritis patients with low disease activity.
-
FDA approval · 2022-07-07FDA Approved: HYDROXYCHLOROQUINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for HYDROXYCHLOROQUINE from Chartwell RX, LLC under an ANDA, making a generic version available.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients [Phase 2, Phase 3]
A multi-phase study comparing Advixa to Humira in healthy adults and later efficacy/safety assessment in rheumatoid arthritis patients is un…
-
FDA approval · 2022-06-17FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) from Immunex Corporation, resulting in labeling changes for the product.…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis [Phase 3]
Open-label extension study results for CDP870 in rheumatoid arthritis completed Phase 3 trial.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial update for olokizumab in moderately to severely active rheumatoid arthritis; results posted indicating efficacy and safety dat…
-
FDA approval · 2022-06-07FDA Approved: NAPROXEN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber's naproxen generic original application for Naproxen. This generic NSAID is approved for relief of pain and inflammation…
-
FDA approval · 2022-06-03FDA Approved: RIABNI — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for RIABNI (rituximab-arrx) from Amgen. The action updates RIABNI’s labeling to reflect its approved…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial update on the long-term safety and efficacy of olokizumab (CDP6038) in active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating BCD-089 in combination with methotrexate for active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial evaluating HLX01 plus methotrexate in moderately to severely active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs [Phase 1, Phase 2]
A randomized, double-blind Phase I/II trial comparing HLX01 to rituximab in patients with moderate to severe rheumatoid arthritis who have i…
-
CLINICAL_TRIALS withdrawal · 2022-05-09Clinical Trial Update: A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis [Phase 4]
A multicenter Phase 4 trial evaluating etanercept and methotrexate for rheumatoid arthritis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Natrunix Versus Methotrexate in Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update comparing Natrunix to methotrexate in rheumatoid arthritis.
-
FDA approval · 2022-05-06FDA Approved: DICLOFENAC SODIUM — Original Application (Apotex Corp.)
FDA approved Apotex Corp's original application for diclofenac sodium tablets, a generic NSAID. This approval enables Apotex to market a gen…
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Auto-injector Real Life Handling in Patients [Phase 3]
A Phase 3 clinical trial evaluating auto-injector real-life handling in patients with rheumatoid arthritis has completed.
-
FDA approval · 2022-05-03FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp. This action constit…